Metformin Regulates Cardiac Ferroptosis to Reduce Metabolic Syndrome-Induced Cardiac Dysfunction
-
Published:2024-08-06
Issue:
Volume:
Page:
-
ISSN:0273-2289
-
Container-title:Applied Biochemistry and Biotechnology
-
language:en
-
Short-container-title:Appl Biochem Biotechnol
Author:
Xu Liancheng, Li Wenwen, Chen Yu, Liu Shan, Liu Guodong, Luo Weihuan, Cao Guanyi, Wang ShipingORCID
Funder
Suqian Sci&Tech Program
Publisher
Springer Science and Business Media LLC
Reference40 articles.
1. Templin, T., Cravo Oliveira Hashiguchi, T., Thomson, B., Dieleman, J., & Bendavid, E. (2019). The overweight and obesity transition from the wealthy to the poor in low- and middle-income countries: A survey of household data from 103 countries. PLoS Medicine, 16(11), e1002968. 2. Sung, H., Siegel, R. L., Torre, L. A., Pearson-Stuttard, J., Islami, F., Fedewa, S. A., Goding Sauer, A., Shuval, K., Gapstur, S. M., Jacobs, E. J., Giovannucci, E. L., & Jemal, A. (2019). Global patterns in excess body weight and the associated cancer burden. CA: A cancer journal for clinicians, 69(2), 88–112. 3. Lusis, A. J., Attie, A. D., & Reue, K. (2008). Metabolic syndrome: From epidemiology to systems biology. Nature Reviews. Genetics, 9(11), 819–830. 4. Mouton, A. J., Li, X., Hall, M. E., & Hall, J. E. (2020). Obesity, hypertension, and cardiac dysfunction: Novel roles of immunometabolism in macrophage activation and inflammation. Circulation Research, 126(6), 789–806. 5. Russell, J., Du Toit, E. F., Peart, J. N., Patel, H. H., & Headrick, J. P. (2017). Myocyte membrane and microdomain modifications in diabetes: Determinants of ischemic tolerance and cardioprotection. Cardiovascular Diabetology, 16(1), 155.
|
|